A phase II study of first-line afatinib for patients aged ≥75 years with EGFR mutation-positive advanced non-small cell lung cancer: North East Japan Study Group trial NEJ027

BACKGROUND: Lung cancer is most common among older individuals. However, polypharmacy and comorbidities, which are also more common in older individuals, can limit treatment options. Previous studies suggest that afatinib can be used safely and effectively in elderly patients. This study investigate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Minegishi, Yuji, Yamaguchi, Ou, Sugawara, Shunichi, Kuyama, Shoichi, Watanabe, Satoshi, Usui, Kazuhiro, Mori, Masahide, Hataji, Osamu, Nukiwa, Toshihiro, Morita, Satoshi, Kobayashi, Kunihiko, Gemma, Akihiko
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7919080/
https://ncbi.nlm.nih.gov/pubmed/33648453
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-07861-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados